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ABSTRACT 
 
Meningitis is a severe and potentially fatal form of tuberculosis. The diagnostic workup involves detection of acid-
fast bacilli in the cerebrospinal fluid by microscopy or culture. However the difficulty in detecting the organism poses a 
challenge to diagnosis. Use of polymerase chain reaction (PCR) in the diagnostic approach to Mycobacterium 
tuberculosis (MTB) meningitis has been reported as a fast and accurate method, with several commercial kits available. 
As an alternative, some institutions have been developing inexpensive in-house assays. In our institution, we use an in-
house PCR for tuberculosis. The performance of our PCR for the diagnosis of MTB meningitis was analyzed in 148 
consecutive patients, using MTB culture as the gold standard. Sensitivity of cerebrospinal fluid PCR for the diagnosis of 
MTB meningitis was 50%, specificity was 98.6%, and concordance with culture was 96% (kappa = 0.52). The 
performance of our PCR is similar to that obtained with the available commercial kits. 
Keywords: Tuberculous meningitis, polymerase chain reaction, acquired immunodeficiency syndrome. 
 
RESUMO 
 
Meningite é uma forma grave e potencialmente fatal de tuberculose. O diagnóstico envolve a detecção de bacilos 
álcool-ácido resistentes no líquido cefalorraquidiano por microscopia ou cultura. Entretanto, a dificuldade de detectar o 
organismo representa um desafio ao diagnóstico. O uso da reação em cadeia da polimerase (PCR) na abordagem 
diagnóstica de meningite causada por Mycobacterium tuberculosis (MTB) tem sido relatado como um método rápido e 
preciso, com diversos kits comerciais disponíveis. Como alternativa, algumas instituições vêm desenvolvendo testes in 
house com baixo custo. Em nossa instituição, usamos PCR in house para tuberculose. O desempenho de nossa PCR 
para o diagnóstico de meningite causada por MTB foi analisado em 148 pacientes consecutivos, usando a cultura do 
MBT como padrão-ouro. A sensibilidade da PCR no líquido cefalorraquidiano para o diagnóstico de meningite causada 
por MTB foi de 50%, especificidade de 98,6% e concordância coma cultura de 96% (kappa = 0,52). O desempenho de 
nossa PCR é semelhante ao obtido com os kits comerciais disponíveis.  
Unitermos: Meningite tuberculosa,  reação em cadeia da polimerase, síndrome da imunodeficiência adquirida. 
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Tuberculosis is a public-health problem of 
global importance. According to the World Health 
Organization (WHO), more than 8 million people 
develop tuberculosis each year, with 2 million 
deaths (1). With the epidemic of human 
immunodeficiency virus (HIV) infection, 
disseminated and extrapulmonary forms are 
increasingly seen. Extrapulmonary involvement is 
found in more than half of acquired 
immunodeficiency syndrome (AIDS) patients, and 
the risk of disseminated disease increases with 
advancing immunosuppression (2). 
Tuberculous meningitis is a potentially fatal 
form of tuberculosis, with serious long-term 
consequences. Confirmation of the diagnosis is 
challenging. The traditional approach of clinical 
data with added biochemical and cytological 
findings of the cerebrospinal fluid (CSF) cannot 
confirm or exclude the condition. Typical results 
include lymphocytic pleocytosis, elevated protein 
and low glucose contents. The diagnostic workup 
also involves detection of acid-fast bacilli (AFB) in 
the CSF by microscopy and culture. Due to the 
paucibacillary characteristic of this condition, 
sensitivity of these tests is low (3,4). Collecting 
large amounts of CSF (30 mL) may provide better 
diagnostic results (4). Some studies indicate that an 
elevated CSF adenosine deaminase (ADA) level 
may support the diagnosis in a proper clinical 
setting (5), but the cut-off value is not clear and 
additional studies are necessary. 
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Use of polymerase chain reaction (PCR) to 
amplify specific regions of Mycobacterium 
tuberculosis (MTB) genome emerged as a tool for 
rapid and accurate diagnosis of tuberculous 
meningitis. The performance of this test has been 
studied since 1990, with results disclosing high 
specificity and variable sensitivity (6-8). The exact 
role of this test in the diagnostic approach remains 
controversial. Its clinical usefulness appears to be in 
smear-negative patients, which occurs in the 
majority of patients with tuberculous meningitis (3). 
There are several commercial MTB PCR kits 
available in the market. Some institutions, most of 
them in developing countries, have been designing 
in-house assays, as an inexpensive alternative. A 
recently published meta-analysis compared the 
accuracy of commercial and in-house kits for 
tuberculous meningitis (3). Sensitivity was of 56 
and 76%, and specificity was 98 and 92%, for 
commercial and in-house kits, respectively. Besides 
the high heterogeneity among studies included, the 
authors concluded that there is no significant 
difference between commercial and in-house 
assays. 
Given that the results of the different in-
house MTB PCR assays are heterogeneous, it is not 
possible to extrapolate data from one institution to 
another. In our institution, a tertiary teaching 
hospital, we use an in-house assay that has not been 
previously validated. 
A study was conducted to analyze the 
accuracy of our PCR to diagnose tuberculous 
meningitis. 
 
METHODS 
 
Design 
A cross-sectional study was conducted 
between January 2005 and May 2006 at Hospital de 
Clínicas de Porto Alegre, located in southern Brazil. 
 
Patients 
Inclusion criteria were all patients with 
suspected tuberculous meningitis, in which CSF 
MTB PCR and MTB cultures were ordered. For 
patients with more than one MTB PCR ordered, 
only the results on the first sample were considered 
in the analysis. 
 
Polymerase chain reaction for M. tuberculosis 
detection 
An aliquot of 140 µL of CSF, previously 
treated with proteinase K (Invitrogen

, São Paulo, 
Brazil), was used for DNA extraction. The DNA 
samples were initially submitted to a nested PCR 
with primers to 65-KDa antigen, common to several 
pathogenic mycobacteria. The first nested PCR was 
performed with the external primers 5’ GCC AAG 
AAG ACC GAT GAC GT 3’ and 5’ TCG TTG 
CCC ACC TTG TCC AT 3’ that amplify a DNA 
fragment of 280 base pairs (bp). Ten microliters of 
CSF DNA were amplified in a 40 µL reaction 
mixture containing 1.25 U of Taq polimerase 
(Super-Therm, JMR Holdings, London, United 
Kingdom), 1.5 mM of MgCl2 buffer, 250 µM of 
deoxynucleoside triphosphates (ABgene

, Epson, 
UK), 100 nM of external “primers” (Invitrogen

, 
Carlbad, USA) and distilled water, totalizing 50 µL. 
The mixture was submitted to a denaturation period 
of 100 s at 94 
o
C, followed by 33 cycles of 
amplification (each cycle consisted of 94 
o
C for 30 
s, 55 
o
C for 30 s and 72 
o
C for 30 s). 
In the second reaction, the amplicon of the 
first DNA reaction was amplified to a DNA 
fragment of 142 bp, using the internal primers 5’ 
CCA ACC CGC TCG GTC TCA A 3’ and 5’ CCG 
ATG GAC TGG TCA CCC 3’. Two microliters of 
the amplicon from the first reaction were amplified 
in a 24 µL reaction mixture containing 1.25 U of 
Taq polymerase (Super-Therm, JMR Holdings, 
London, United Kingdom), 1.5 mM of MgCl2 
buffer, 250 µM of deoxynucleoside triphosphates 
(ABgene

, Epson, UK), 100 nM of internal primers 
(Invitrogen

, Carlbad, USA) and distilled water, 
totalizing 26 µL. The mixture was submitted to a 
denaturation period of 45 s at 94 
o
C, followed by 33 
cycles of amplification (each cycle consisted of 94 
o
C for 20 s, 55 
o
C for 20 s and 72 
o
C for 30 s). 
In those samples which Mycobacterium sp. 
DNA was amplified, a second nested PCR was 
performed. For the amplification of MBT complex 
DNA, external primers TB290 5’ GGC GGG ACA 
ACG CCG AAT TGC GAA 3’ and TB856 5’ CGA 
GCG TAG GCG TCG GTG ACA AAG 3’ were 
used to generate a fragment of 600 bp. Ten 
microliters of CSF DNA were amplified in a 40 µL 
reaction mixture containing 1.25 U of Taq 
polymerase (Super-Therm, JMR Holdings, London, 
United Kingdom), 1.5 mM of MgCl2 buffer, 250 
µM of deoxynucleoside triphosphates (ABgene

, 
Epson, UK), 500 nM of external primers 
(Invitrogen

, Carlbad, USA) and distilled water, 
totalizing 50 µL. The mixture was submitted to a 
denaturation period of 100 s at 94 
o
C, followed by 
33 cycles of amplification (each cycle consisted of 
94 
o
C for 30 s, 65 
o
C for 30 s and 72 
o
C for 30 s). 
In the second reaction, the amplicon of the 
first DNA reaction was amplified to a DNA 
fragment of 170 bp, using the internal primers 
TB500 5’ TAC TAC GAC CAG ATC 3’ and 
TB607 5’ TTG GTG ATC AGC CGT 3’ (9). Two 
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microliters of the amplicon from the first reaction 
were amplified in a 24 µL reaction mixture 
containing 1.25 U of Taq polymerase (Super-
Therm, JMR Holdings, London, United Kingdom), 
1.5 mM of MgCl2 buffer, 250 µM of 
deoxynucleoside triphosphates (ABgene

, Epson, 
UK), 500 nM of internal primers (Invitrogen

, 
Carlbad, USA) and distilled water, totalizing 26 µL. 
The mixture was submitted to a denaturation period 
of 45 s at 94 
o
C, followed by 33 cycles of 
amplification (each cycle consisted of 94 
o
C for 20 
s, 52 
o
C for 20 s and 72 
o
C for 30 s). 
Negative (distilled water) and positive 
controls (H37RV culture of Mycobacterium) were 
used for all reactions. Visualization of the 
amplification products was performed using 10 µL 
of the final volume in 0.5 µg/mL ethidium bromide 
2% agarose gel electrophoresis under ultraviolet 
light. 
 
M. tuberculosis cultures 
All clinical specimens submitted for 
mycobacterial culture were processed and 
simultaneously cultured on BACTEC broth medium 
(Becton Dickinson, Sparks, Md.) and Lowenstein-
Jensen (LJ) solid medium. The BACTEC broth 
medium (12B) contains palmitic acid labeled with 
14
C; the mycobacteria catabolize the 
14
C-labeled 
palmitic acid and release 
14
CO2; the 
14
CO2 in the 
headspace gas is measured by an automated 
radiometric system (BACTEC 460 TB). The 
characteristic mycobacteria colonial morphology 
was evaluated on LJ and AFB smears were also 
performed on the sediments. Differentiation of 
mycobacterial isolates as MTB or Mycobacterium 
sp. other than tuberculosis (MOTT) was based on 
the BACTEC NAP test. 
Positive control standard culture of MBT 
H37RV was processed with every batch of 
specimens. 
 
Criteria for diagnosing tuberculous meningitis 
All patient records were revised and a clinical 
diagnosis of MTB meningitis was considered when 
the patient had a positive culture for MTB in CSF. 
An alternative diagnosis was considered present 
when MTB CSF cultures were negative. 
 
Statistical analysis 
A two-by-two table was performed using the 
results obtained, with sensitivity, specificity, 
likelihood ratios and predictive values derived from 
it. Intertest agreement was evaluated by 
concordance and kappa value. Statistical analysis 
was performed using the software Statistical 
Package for the Social Sciences 13.0 (SPSS, Inc., 
Chicago, IL). 
 
Bioethics 
The project was approved by the Ethics 
Committee of the institution. 
 
RESULTS 
 
A total of 148 patients were included in the 
analysis. The baseline characteristics of the patients 
are described in Table 1. Positive CSF cultures were 
found in 4% and positive CSF PCR in 3.3 % of the 
patients. Of the five patients with positive CSF 
PCR, two patients had negative CSF cultures. All 
patients with positive CSF cultures or PCR were 
considered to have MTB meningitis and received 
specific treatment. 
The performance of CSF PCR was compared 
with CSF cultures results (Table 2).  
 
 
Table 1. Patients’ baseline characteristics 
 
Age mean (SD)   38 (16) 
Male sex n (%)   88 (59.5) 
HIV + n (%)   106 (71.6) 
Alternative diagnosis n (%) 100 (67)  
 Cryptococcus meningitis  15 (15) 
 CNS Toxoplasmosis  14 (14) 
 Viral meningitis   9 (9) 
 Neurosyphilis   4 (4) 
 Bacterial meningitis  4 (4) 
 Other diagnosis   54 (54) 
CNS= central nervous system; HIV= human immunodeficiency 
syndrome;  n= number of patients; SD= standard deviation. 
 
 
Table 2. Performance of polymerase chain 
reaction against culture results 
 
    MTB culture  
Sensitivity   0.50 (0.18-0.81) 
Specificity   0.98 (0.95-0.99) 
PPV    0.60 (0.23-0.88) 
NPV    0.97 (0.94-0.99) 
LR+    35.5 (7.2-174.4) 
LR-    0.50 (0.22-1.12) 
Agreement   0.96 (0.18)  
Kappa    0.52 (0.16-0.89) 
NPV = negative predictive value; PPV = positive predictive 
value; LR+ = positive likelihood ratio;  LR- = negative 
likelihood ratio. 
* Data are shown with confidence interval of 95% in brackets, 
except for agreement, which is shown with standard error. 
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When data from 47 patients without other 
diagnoses were analyzed, the high specificity 
(95.1%; 95% CI 83.9-98.7) and positive likelihood 
ratio (10.2; 95%CI 2.1-49.3), with similar 
sensitivity for the M. tuberculosis PCR (50%; 
95%CI 18.8-81.2), persisted. 
 
DISCUSSION 
 
In our study, a large number of patients 
without definitive diagnosis of tuberculous 
meningitis were included, which reflects the 
scenario of a tertiary teaching hospital with a great 
attendance of HIV positive patients that present 
with multiple CNS syndromes similar to 
tuberculous meningitis. This can explain the low 
prevalence of MTB meningitis among those with 
high clinical suspicion of the condition. 
Although anti-tuberculous treatment has been 
offered to 17% of the patients, the MTB culture 
positivity was much lower (4%). Some aspects can 
explain the discrepancy. The paucibacillarity of the 
condition in CSF with few microorganisms able to 
grow and previous use of anti-tuberculous drugs 
lower the sensitivity of this method, considered the 
gold standard for diagnosis. In addition, 
presumptive diagnosis can be overestimated. In an 
endemic region for tuberculosis, clinical suspicious 
of MTB meningitis, a potentially fatal condition, 
mandates treatment despite lack of confirmation. 
In our institution, even without a clinical 
validation, MTB PCR has been available as a 
diagnostic tool since 2000. This is the first study to 
analyze the performance of our MTB PCR in its 
real clinical setting. The high specificity found in 
this study is in agreement with previously reported 
data (3,6,7). In a meta-analysis published by Pai M. 
et al. (3), the sensitivity of commercial kits was 
56%, similar to that found in the present study. A 
positive MTB PCR is virtually diagnostic of 
tuberculous meningitis. Taking into consideration 
the low sensitivity of MTB culture and the long 
time required for results, the PCR aggregates in 
saving time and increasing sensitivity for MTB 
diagnosis. 
We provide a methodologically detailed in-
house technique for MTB PCR that can be 
reproduced by others. In contrast to commercial 
kits, in-house techniques offer the advantage of 
lower costs, maintaining similar diagnostic 
performance. This is a very important issue in 
developing countries where tuberculosis is epidemic 
and few financial resources are available to public 
health. 
In order to improve the validation of the 
MTB PCR used in our institution, we aim to expand 
the number of patients and analyze MTB PCR 
performance in other biological materials. 
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